Halozyme Therapeutics Inc. (HALO)

$ 65.13
   
  • Change Today:
    $1.09
  • 52 Week High: $70.14
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 148
  • Market Cap: $9,463m
  • RiskGrade: 189

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,251.76 723.94 550.00¢ 11.8 n/a n/a n/a 0.0%
31-Dec-26 1,477.69 892.48 726.67¢ 9.0 0.3 +32% n/a 0.0%
31-Dec-27 1,680.97 1,083.81 923.50¢ 7.1 0.3 +27% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 65.13
Change Today $ 1.09
% Change 1.70 %
52 Week High $70.14
52 Week Low $42.57
Volume 148
Shares Issued 145.30m
Market Cap $9,463m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Aug-2025

Time Volume / Share Price
16:00 282,355 @ $65.13
15:59 100 @ $65.13
15:59 176 @ $65.13
15:59 100 @ $65.13
15:59 100 @ $65.13

Top of Page